• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparator choices in pharmacoepidemiology studies of Alzheimer's disease.

作者信息

Her Qoua L, Kahrs Jacob C, Stürmer Til

机构信息

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

出版信息

Nat Aging. 2023 Jul;3(7):791-792. doi: 10.1038/s43587-023-00417-x. Epub 2023 May 22.

DOI:10.1038/s43587-023-00417-x
PMID:37217663
Abstract
摘要

相似文献

1
Comparator choices in pharmacoepidemiology studies of Alzheimer's disease.阿尔茨海默病药物流行病学研究中的对照选择
Nat Aging. 2023 Jul;3(7):791-792. doi: 10.1038/s43587-023-00417-x. Epub 2023 May 22.
2
Reply to: Comparator choices in pharmacoepidemiology studies of Alzheimer's disease.回复：阿尔茨海默病药物流行病学研究中的对照选择
Nat Aging. 2023 Jul;3(7):793-795. doi: 10.1038/s43587-023-00418-w. Epub 2023 May 22.
3
Pharmacoepidemiology of tacrine in Alzheimer's disease.他克林在阿尔茨海默病中的药物流行病学
Methods Find Exp Clin Pharmacol. 1996;18 Suppl B:77-8.
4
Policy-induced selection bias in pharmacoepidemiology: The example of coverage for Alzheimer's medications in British Columbia.政策诱导的药物流行病学选择偏倚：以不列颠哥伦比亚省阿尔茨海默病药物覆盖为例。
Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1067-1076. doi: 10.1002/pds.4804. Epub 2019 Jul 3.
5
Impact of opioid initiation on antipsychotic and benzodiazepine and related drug use among persons with Alzheimer's disease.阿片类药物起始治疗对阿尔茨海默病患者抗精神病药和苯二氮䓬类药物及相关药物使用的影响。
Int Psychogeriatr. 2018 Jul;30(7):947-956. doi: 10.1017/S1041610217002897. Epub 2018 Mar 21.
6
Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.多奈哌齐、卡巴拉汀和加兰他敏治疗阿尔茨海默病的临床疗效及成本效益：一项快速系统评价
Health Technol Assess. 2001;5(1):1-137. doi: 10.3310/hta5010.
7
Disease-modifying therapies in Alzheimer's disease: how far have we come?阿尔茨海默病的疾病修饰疗法：我们取得了多大进展？
Drugs. 2006;66(16):2075-93. doi: 10.2165/00003495-200666160-00004.
8
Hospital-Treated Pneumonia Associated with Opioid Use Among Community Dwellers with Alzheimer's Disease.社区居住的阿尔茨海默病患者中与使用阿片类药物相关的医院治疗性肺炎
J Alzheimers Dis. 2019;69(3):807-816. doi: 10.3233/JAD-181295.
9
Rationale of Medication Choices in Patients With Alzheimer's Disease.阿尔茨海默病患者用药选择的基本原理
J Am Med Dir Assoc. 2024 Aug;25(8):105104. doi: 10.1016/j.jamda.2024.105104. Epub 2024 Jun 19.
10
Detection of medications associated with Alzheimer's disease using ensemble methods and cooperative game theory.使用集成方法和合作博弈论检测与阿尔茨海默病相关的药物。
Int J Med Inform. 2020 Sep;141:104142. doi: 10.1016/j.ijmedinf.2020.104142. Epub 2020 May 24.

引用本文的文献

1
A Genetics-guided Integrative Framework for Drug Repurposing: Identifying Anti-hypertensive Drug Telmisartan for Type 2 Diabetes.一种用于药物再利用的遗传学引导综合框架：确定替米沙坦为2型糖尿病的抗高血压药物。
medRxiv. 2025 Mar 23:2025.03.22.25324223. doi: 10.1101/2025.03.22.25324223.
2
Genetically Proxied Phosphodiesterase Type 5 (PDE5) Inhibition and Risk of Dementia: A Drug Target Mendelian Randomization Study.基因代理的5型磷酸二酯酶（PDE5）抑制与痴呆风险：一项药物靶点孟德尔随机化研究
Mol Neurobiol. 2025 Jun;62(6):7864-7874. doi: 10.1007/s12035-025-04732-9. Epub 2025 Feb 14.

本文引用的文献

1
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Respir J. 2023 Jan 6;61(1). doi: 10.1183/13993003.00879-2022. Print 2023 Jan.
2
Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's disease.基于表型的计算网络医学发现结合保险记录数据挖掘，鉴定西地那非是治疗阿尔茨海默病的候选药物。
Nat Aging. 2021 Dec;1(12):1175-1188. doi: 10.1038/s43587-021-00138-z. Epub 2021 Dec 6.
3
Core concepts in pharmacoepidemiology: Confounding by indication and the role of active comparators.
药物流行病学的核心概念：指示性混杂和活性对照物的作用。
Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):261-269. doi: 10.1002/pds.5407. Epub 2022 Jan 27.
4
Where to begin? Thirty must-read papers for newcomers to pharmacoepidemiology.从哪里开始呢？药物流行病学新手必读的30篇论文。
Pharmacoepidemiol Drug Saf. 2022 Feb;31(2):257-259. doi: 10.1002/pds.5382. Epub 2021 Nov 17.
5
Pulmonary arterial hypertension in the emergency department: A focus on medication management.急诊科肺动脉高压：关注药物治疗管理。
Am J Emerg Med. 2021 Sep;47:101-108. doi: 10.1016/j.ajem.2021.03.072. Epub 2021 Mar 26.
6
Phosphodiesterase Type-5 Inhibitor Prescription Patterns in the United States Among Men With Erectile Dysfunction: An Update.美国男性勃起功能障碍患者中磷酸二酯酶-5 抑制剂的处方模式：更新。
J Sex Med. 2020 May;17(5):941-948. doi: 10.1016/j.jsxm.2020.01.027. Epub 2020 Mar 3.
7
The importance and implications of comparator selection in pharmacoepidemiologic research.药物流行病学研究中对照选择的重要性及影响
Curr Epidemiol Rep. 2018 Sep;5(3):272-283. doi: 10.1007/s40471-018-0155-y. Epub 2018 Jul 6.
8
Network-based approach to prediction and population-based validation of in silico drug repurposing.基于网络的药物重定位预测方法及基于人群的验证。
Nat Commun. 2018 Jul 12;9(1):2691. doi: 10.1038/s41467-018-05116-5.
9
The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application.药物流行病学中的活性对照、新用户研究设计：历史基础与当代应用。
Curr Epidemiol Rep. 2015 Dec;2(4):221-228. doi: 10.1007/s40471-015-0053-5. Epub 2015 Sep 30.
10
Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results.老年人群药物流行病学数据库研究中限制水平的提高及其与随机试验结果的比较。
Med Care. 2007 Oct;45(10 Supl 2):S131-42. doi: 10.1097/MLR.0b013e318070c08e.